查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
ALPHA乳清蛋白的全球市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按应用、按地区
市场调查报告书
商品编码
1397294

ALPHA乳清蛋白的全球市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按应用、按地区

Alpha Lactalbumin Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 200 Pages | 商品交期: 2-5个工作天内

价格
简介目录

全球ALPHA-乳清蛋白市场规模预计将在2024年至2031年间显着成长。 预计到 2031 年，该市场将从 2.14 亿美元成长到约 3.85 亿美元。

这一成长的主要驱动力是婴儿配方奶粉市场的强劲扩张，这主要是由全球职业女性人口不断增加所推动的。 ALPHA-乳清蛋白是人类母乳中发现的主要蛋白质，被认为含有必需胺基酸。 事实证明，将其添加到婴儿配方奶粉中可以减少胃肠道餵食相关事件，使其成为寻求母乳替代品的母亲的热门选择。 随着世界劳动人口的增加，对婴儿配方奶粉的需求不断增加，直接拉动了对ALPHA-乳清蛋白的需求。

此外，全球加工食品市场对ALPHA-乳清蛋白市场也产生重大影响。 消费者便利性、安全性和生活方式偏好的变化导致对富含 ALPHA-乳清蛋白的加工食品的需求增加。

主要的ALPHA-乳清蛋白製造商正在透过采取各种扩张策略积极增加其市场份额。 每个製造商都致力于根据客户要求提供客製化解决方案，同时投资研发以提高产品品质。 遵守严格的行业标准和法规对于製造过程至关重要。 此外，这些製造商正在提高生产能力并升级加工技术和设备，以满足不同最终用途领域不断增长的需求。

由于快速城市化、可支配收入增加以及西方文化对发展中国家的影响，世界对乳製品的需求正在上升。 芬兰、丹麦、德国、冰岛和法国等国家对乳酪和乳酪产品的需求激增是促进ALPHA-乳清蛋白成长的主要因素。

本报告调查了全球 ALPHA-乳清蛋白市场，并提供了市场概述以及进入市场的公司按应用、地区和竞争趋势划分的趋势。

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 乌克兰和俄罗斯之间衝突的影响
  • 经济概况
  • PESTLE分析

第 3 章价格分析，2018-2023

第 4 章 2018-2031 年全球 ALPHA-乳清蛋白市场展望

  • 2018-2031 年全球 ALPHA-乳清蛋白市场前景（按应用、价值（百万美元）、数量（百万单位））
  • 2018-2031 年全球 ALPHA-乳清蛋白市场前景（按地区、价值（百万美元）、数量（百万单位））

第五章北美 ALPHA-乳清蛋白市场展望，2018-2031

第 6 章欧洲 ALPHA-乳清蛋白市场展望，2018-2031

第 7 章亚太地区 ALPHA-乳清蛋白市场展望，2018-2031

第 8 章拉丁美洲 ALPHA-乳清蛋白市场前景，2018-2031

第 9 章 2018-2031 年中东与非洲 ALPHA-乳清蛋白市场前景

第10章竞争态势

  • 2023 年公司市占率分析
  • 竞争力仪表板
  • 公司简介
    • Arla Foods Ingredients Group P/S
    • Hilmar Ingredients
    • Milk Specialties Global
    • VWR International, LLC
    • Agropur, Inc.
    • Xuchang Shangke Chemical Co., Ltd.
    • Merck KGaA
    • Abcam PLC
    • Shanghai Korain Biotech Co., Ltd.
    • FrieslandCampina N.V.
    • Giellepi Spa
    • Novus Biologicals, Inc.

第11章附录

简介目录

The global Alpha Lactalbumin market is set to experience an impressive growth trajectory during the period from 2024 to 2031. The market size is projected to increase from US$ 214 million to approximately US$ 385 million by 2031, according to a recent market study report by Fairfield Market Research.

Rising Demand Driven by Surging Infant Formula Market

The key driver of this growth is the robust expansion of the infant formula market, largely fueled by the increasing population of working women worldwide. Alpha Lactalbumin, a dominant protein in human milk, is being recognized for its essential amino acid content. Its inclusion in infant formula has been shown to reduce gastrointestinal feeding-related events, making it a popular choice for mothers seeking an alternative to breast milk. With the global workforce seeing a rising number of women, the demand for infant formula is on the rise, directly boosting the demand for alpha lactalbumin.

Processed Food Market and Lifestyle Changes Fueling Demand

Furthermore, the global processed food market is making a significant impact on the alpha lactalbumin market. The convenience, safety, and changing lifestyle preferences of consumers have led to increased demand for processed food products that often contain alpha lactalbumin.

Manufacturers Focusing on Quality and Expansion

Leading alpha lactalbumin manufacturers are actively expanding their market share by adopting various expansion strategies. They are dedicated to providing customized solutions to meet customer requirements while investing in research and development to enhance product quality. Compliance with strict industry standards and regulations is paramount in their production processes. Additionally, these manufacturers are increasing production capacity and upgrading their processing technologies and equipment to meet the growing demand from diverse end-use segments.

Rising Dairy Product Demand Boosts Alpha-Lactalbumin

The global demand for dairy products is on the rise due to rapid urbanization, increased disposable income, and the influence of Western culture in developing countries. This surge in demand for cheese and cheese products in countries such as Finland, Denmark, Germany, Iceland, and France is a major factor contributing to the growth of alpha lactalbumin.

Consumer-Centric Labeling Enhances Market Expansion

Consumer awareness about the ingredients they consume is at an all-time high. Brands in the sports nutrition industry are responding to this demand by providing detailed package information, including the origin of ingredients and sustainable farming practices. The incorporation of natural and plant-based ingredients is also a priority for these brands.

North America and European Countries Attracting Manufacturers

North America and European countries have become hubs for alpha lactalbumin manufacturers due to the increasing demand for fortified and nutritional foods in these regions. High disposable income, a preference for premium products, and growing health and wellness consciousness among consumers are driving significant opportunities for alpha lactalbumin manufacturers.

Germany Dominates the European Landscape

Germany stands out as the dominant country among European nations in the alpha lactalbumin market. The increasing demand for nutritional products, high disposable income, and a growing consumer base seeking health and wellness benefits have contributed to Germany's remarkable growth in this sector.

Competitive Landscape

Major players in the global alpha lactalbumin market, including Arla Foods Ingredients Group P/S, Hilmar Ingredients, and Milk Specialties Global, Inc., are actively expanding their presence. Their strategies involve business expansion, increased production capacity, and innovative product offerings.

Key Companies Profiled:

  • Arla Foods Ingredients Group P/S
  • Hilmar Ingredients
  • Milk Specialties Global
  • VWR International, LLC
  • Agropur, Inc.
  • Xuchang Shangke Chemical Co., Ltd.
  • Merck KGaA
  • Abcam PLC
  • Shanghai Korain Biotech Co., Ltd.
  • FrieslandCampina N.V.
  • Giellepi Spa
  • Novus Biologicals, Inc.

With a promising outlook driven by multiple factors, the alpha lactalbumin market is poised for substantial growth in the coming years. For more detailed insights, please refer to the full market study report by Fairfield Market Research.

Market Segmentation

By Application:

  • Infant Formula
  • Clinical Nutrition
  • Sports Nutrition
  • Nutraceuticals
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Alpha Lactalbumin Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2018 - 2023

  • 3.1. Global Average Price Analysis, by Application, US$ Per Unit, 2018 - 2023
  • 3.2. Prominent Alpha Lactalbumin Market Markers Prices
  • 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Alpha Lactalbumin Market Outlook, 2018 - 2031

  • 4.1. Global Alpha Lactalbumin Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Infant Formula
      • 4.1.1.2. Clinical Nutrition
      • 4.1.1.3. Sports Nutrition
      • 4.1.1.4. Nutraceuticals
      • 4.1.1.5. Others
  • 4.2. Global Alpha Lactalbumin Market Outlook, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. North America
      • 4.2.1.2. Europe
      • 4.2.1.3. Asia Pacific
      • 4.2.1.4. Latin America
      • 4.2.1.5. Middle East & Africa

5. North America Alpha Lactalbumin Market Outlook, 2018 - 2031

  • 5.1. North America Alpha Lactalbumin Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Infant Formula
      • 5.1.1.2. Clinical Nutrition
      • 5.1.1.3. Sports Nutrition
      • 5.1.1.4. Nutraceuticals
      • 5.1.1.5. Others
  • 5.2. North America Alpha Lactalbumin Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. U.S. Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.2.1.2. Canada Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Alpha Lactalbumin Market Outlook, 2018 - 2031

  • 6.1. Europe Alpha Lactalbumin Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Infant Formula
      • 6.1.1.2. Clinical Nutrition
      • 6.1.1.3. Sports Nutrition
      • 6.1.1.4. Nutraceuticals
      • 6.1.1.5. Others
  • 6.2. Europe Alpha Lactalbumin Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Germany Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.2.1.2. U.K. Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.2.1.3. France Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.2.1.4. Italy Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.2.1.5. Turkey Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.2.1.6. Russia Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.2.1.7. Rest of Europe Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Alpha Lactalbumin Market Outlook, 2018 - 2031

  • 7.1. Asia Pacific Alpha Lactalbumin Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Infant Formula
      • 7.1.1.2. Clinical Nutrition
      • 7.1.1.3. Sports Nutrition
      • 7.1.1.4. Nutraceuticals
      • 7.1.1.5. Others
  • 7.2. Asia Pacific Alpha Lactalbumin Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. China Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.2.1.2. Japan Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.2.1.3. South Korea Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.2.1.4. India Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.2.1.5. Southeast Asia Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.2.1.6. Rest of Asia Pacific Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Alpha Lactalbumin Market Outlook, 2018 - 2031

  • 8.1. Latin America Alpha Lactalbumin Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Infant Formula
      • 8.1.1.2. Clinical Nutrition
      • 8.1.1.3. Sports Nutrition
      • 8.1.1.4. Nutraceuticals
      • 8.1.1.5. Others
  • 8.2. Latin America Alpha Lactalbumin Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Brazil Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.2.1.2. Mexico Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.2.1.3. Argentina Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.2.1.4. Rest of Latin America Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Alpha Lactalbumin Market Outlook, 2018 - 2031

  • 9.1. Middle East & Africa Alpha Lactalbumin Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Infant Formula
      • 9.1.1.2. Clinical Nutrition
      • 9.1.1.3. Sports Nutrition
      • 9.1.1.4. Nutraceuticals
      • 9.1.1.5. Others
  • 9.2. Middle East & Africa Alpha Lactalbumin Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 9.2.1. Key Highlights
      • 9.2.1.1. GCC Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.2.1.2. South Africa Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.2.1.3. Egypt Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.2.1.4. Nigeria Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 9.2.1.5. Rest of Middle East & Africa Alpha Lactalbumin Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 9.2.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

  • 10.1. Company Market Share Analysis, 2023
  • 10.2. Competitive Dashboard
  • 10.3. Company Profiles
    • 10.3.1. Arla Foods Ingredients Group P/S
      • 10.3.1.1. Company Overview
      • 10.3.1.2. Product Portfolio
      • 10.3.1.3. Financial Overview
      • 10.3.1.4. Business Strategies and Development
    • 10.3.2. Hilmar Ingredients
      • 10.3.2.1. Company Overview
      • 10.3.2.2. Product Portfolio
      • 10.3.2.3. Financial Overview
      • 10.3.2.4. Business Strategies and Development
    • 10.3.3. Milk Specialties Global
      • 10.3.3.1. Company Overview
      • 10.3.3.2. Product Portfolio
      • 10.3.3.3. Financial Overview
      • 10.3.3.4. Business Strategies and Development
    • 10.3.4. VWR International, LLC
      • 10.3.4.1. Company Overview
      • 10.3.4.2. Product Portfolio
      • 10.3.4.3. Financial Overview
      • 10.3.4.4. Business Strategies and Development
    • 10.3.5. Agropur, Inc.
      • 10.3.5.1. Company Overview
      • 10.3.5.2. Product Portfolio
      • 10.3.5.3. Financial Overview
      • 10.3.5.4. Business Strategies and Development
    • 10.3.6. Xuchang Shangke Chemical Co., Ltd.
      • 10.3.6.1. Company Overview
      • 10.3.6.2. Product Portfolio
      • 10.3.6.3. Financial Overview
      • 10.3.6.4. Business Strategies and Development
    • 10.3.7. Merck KGaA
      • 10.3.7.1. Company Overview
      • 10.3.7.2. Product Portfolio
      • 10.3.7.3. Financial Overview
      • 10.3.7.4. Business Strategies and Development
    • 10.3.8. Abcam PLC
      • 10.3.8.1. Company Overview
      • 10.3.8.2. Product Portfolio
      • 10.3.8.3. Financial Overview
      • 10.3.8.4. Business Strategies and Development
    • 10.3.9. Shanghai Korain Biotech Co., Ltd.
      • 10.3.9.1. Company Overview
      • 10.3.9.2. Product Portfolio
      • 10.3.9.3. Financial Overview
      • 10.3.9.4. Business Strategies and Development
    • 10.3.10. FrieslandCampina N.V.
      • 10.3.10.1. Company Overview
      • 10.3.10.2. Product Portfolio
      • 10.3.10.3. Financial Overview
      • 10.3.10.4. Business Strategies and Development
    • 10.3.11. Giellepi Spa
      • 10.3.11.1. Company Overview
      • 10.3.11.2. Product Portfolio
      • 10.3.11.3. Financial Overview
      • 10.3.11.4. Business Strategies and Development
    • 10.3.12. Novus Biologicals, Inc.
      • 10.3.12.1. Company Overview
      • 10.3.12.2. Product Portfolio
      • 10.3.12.3. Financial Overview
      • 10.3.12.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations